Alyaa H. Kamhawy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alyaa H. Kamhawy has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed F. Amer
Department of Child Health, National Research Centre, Giza, Egypt
1 shared publication - Enas R. Abdel Hameed
Child Health Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Giza, Egypt
1 shared publication - Ghada M. El-Kassas
Department of Child Health, National Research Centre, Giza, Egypt
1 shared publication Hanaa H. Ahmed
Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Giza, Egypt
1 shared publication- Lobna S. Sherif
Department of Child Health, National Research Centre, Egypt
1 shared publication - Maged A. El Wakeel
Department of Child Health, National Research Centre, Giza, Egypt
1 shared publication
Latest Publications
- Open Access
- 20 March 2024
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 17 (1) , 171-180
Association Between Cord Blood Placental Growth Factor Level, Fetal Doppler Parameters and Neonatal Growth Measures
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.
- 20 March 2024
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 17 (1) , 171-180
Open AccessAssociation Between Cord Blood Placental Growth Factor Level, Fetal Doppler Parameters and Neonatal Growth Measures
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.
- Open Access
- 20 December 2022
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 15 (4) , 2085-2098
Zinc Sulfate and Omega-3: Do They Have a Role in Environmental Enteric Dysfunction ?
Introduction: Environmental enteric dysfunction (EED) is a subclinical, chronic inflammatory condition of the gut. The purpose of the study: The purpose of this study is to evaluate the effects of zinc sulphate and omega-3 supplementation on anthropometric measurements and faecal EED biomarkers (α-1-antitrypsin (AAT), Neopterin (NEO), and Myeloperoxidase (MPO) in underweight and stunted children as an intervention for EED. Subjects and Methods: An interventional study included 105 underweight and stunted children, divided into two subgroups: one subjected to intervention with zinc supplementation (55 children) and the other subjected to intervention with omega-3 supplementation (50 children) for 6 months. Assessment of anthropometric measurements and faecal EED biomarkers: AAT, NEO, and MPO. Results: Regarding the zinc intervention group, post-intervention weight, weight z score, height, height z score, and BMI z score were highly significantly improved after 6 months of zinc supplementation (p value ≤ 0.001). Serum zinc level was highly significant increased after supplementation (p value ≤ 0.001), while AAT and NEO were highly significant and significant decreased (p value ≤ 0.001) (p value ≤ 0.05) respectively. Regarding the omega-3 intervention group, post-intervention weight, weight z score, height, and height z score were highly significantly improved after 6 months of omega-3 supplementation (p value ≤ 0.001). Meanwhile, no significant change was observed for serum iron and zinc level (p value ≥ 0.05) or EED faecal markers except for AAT, which was highly significant for decreasing after supplementation (p value ≤ 0.001). A significant increase in weight, height, and serum zinc level was observed in the zinc supplementation group more than in the omega-3 supplementation group (p value ≤ 0.05). Alongside no significant difference post intervention in EED fecal markers between the two groups (p value ≥ 0.05). Conclusion: No definite drug intervention or supplementation is documented as appropriate management. Zinc sulphate supplementation is thought to be more beneficial than omega-3 supplementation, as evidenced by the improvement of anthropometric measurements and decrease of EED faecal markers.
- 20 December 2022
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 15 (4) , 2085-2098
Open AccessZinc Sulfate and Omega-3: Do They Have a Role in Environmental Enteric Dysfunction ?
Introduction: Environmental enteric dysfunction (EED) is a subclinical, chronic inflammatory condition of the gut. The purpose of the study: The purpose of this study is to evaluate the effects of zinc sulphate and omega-3 supplementation on anthropometric measurements and faecal EED biomarkers (α-1-antitrypsin (AAT), Neopterin (NEO), and Myeloperoxidase (MPO) in underweight and stunted children as an intervention for EED. Subjects and Methods: An interventional study included 105 underweight and stunted children, divided into two subgroups: one subjected to intervention with zinc supplementation (55 children) and the other subjected to intervention with omega-3 supplementation (50 children) for 6 months. Assessment of anthropometric measurements and faecal EED biomarkers: AAT, NEO, and MPO. Results: Regarding the zinc intervention group, post-intervention weight, weight z score, height, height z score, and BMI z score were highly significantly improved after 6 months of zinc supplementation (p value ≤ 0.001). Serum zinc level was highly significant increased after supplementation (p value ≤ 0.001), while AAT and NEO were highly significant and significant decreased (p value ≤ 0.001) (p value ≤ 0.05) respectively. Regarding the omega-3 intervention group, post-intervention weight, weight z score, height, and height z score were highly significantly improved after 6 months of omega-3 supplementation (p value ≤ 0.001). Meanwhile, no significant change was observed for serum iron and zinc level (p value ≥ 0.05) or EED faecal markers except for AAT, which was highly significant for decreasing after supplementation (p value ≤ 0.001). A significant increase in weight, height, and serum zinc level was observed in the zinc supplementation group more than in the omega-3 supplementation group (p value ≤ 0.05). Alongside no significant difference post intervention in EED fecal markers between the two groups (p value ≥ 0.05). Conclusion: No definite drug intervention or supplementation is documented as appropriate management. Zinc sulphate supplementation is thought to be more beneficial than omega-3 supplementation, as evidenced by the improvement of anthropometric measurements and decrease of EED faecal markers.